Divi's Laboratories Limited Overview
Pro stress-test →Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company is a leading pharmaceutical company with custom synthesis business driving growth amid ongoing pricing pressures in the generics segment. Divi's manufactures Generic APIs, Intermediates, and Nutraceutical Ingredients, and offers Custom Synthesis of APIs to Big Pharma, providing a competitive advantage throughout the entire product lifecycle.
Strategic Profile
Pro stress-test →The company manufactures 30 Large Volume Generic APIs and offers Custom Synthesis of APIs and Intermediates for global companies with a portfolio of products across diverse therapeutic areas. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world. Divis Laboratories' strong performance in custom synthesis business demonstrates the company's resilience and strategic positioning in the pharmaceutical industry, while continuing to invest in future growth opportunities, particularly in custom synthesis and peptide development.
Competitive Landscape
Pro stress-test →Zydus Lifesciences, Wockhardt, Syngene International, Evotec, and Intas Pharmaceuticals are among the competitors of Divi's Laboratories. Major competitors include Laurus Labs, Neuland Laboratories, Acutaas Chemicals, Granules India, Alivus Life Sciences, Aarti Pharmalabs, and Shilpa Medicare. Divis maintains competitive advantage through scale, geographic diversification, and dual focus on generic and custom synthesis segments.
Industry Context
Divi's Laboratories Limited operates in Pharmaceutical Manufacturing (Active Pharmaceutical Ingredients & Contract Manufacturing).
Key facts
Founded: 1990 · Headquarters: Hyderabad, India · Employees: 10000+ · Revenue: $1.16B · Market cap: $18.9B